Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII

Blood

Volumn 93, Issue 4, 1999, Pages 1237-1244

  Hunault, Mathilde ^b   Arbini, Arnaldo A ^b   Carew, Josephine A ^b   Peyvandi, Flora ^b   Bauer, Kenneth A ^a  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; CYSTEINE PROTEINASE; EPIDERMAL GROWTH FACTOR;

ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CHO CELL; DISULFIDE BOND; ENDOPLASMIC RETICULUM; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN;

EID: 0033557948     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.4.1237.404k02_1237_1244     Document Type: Article

References (40)

1. Fair DS: Quantitation of factor VII in the plasma of normal and warfarin-trealed individuals by radioimmunoassay. Blood 62:784, 1983
2. Bauer KA, Kass BL, ten Gate H, Hawiger JJ, Rosenberg RD: Factor IX is activated in vivo by the tissue factor mechanism. Blood 76:731, 1990
3. Osterud B, Rapaport S: Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci US A 74:5260, 1977
4. Hagen FS, Gray CL, O'Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW: Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 83:2412, 1986
5. Thim L, Bjoern S, Christensen M, Nicolaisen EM, Lund-Hansen T, Pedersen AH, Hedner U: Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells. Biochemistry 27:7785, 1988
6. 2-Glc) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z. J Biol Chem 264:20320, 1989
7. Ragni MV, Lewis JH, Spero JA, Hasiba U: Factor VII deficiency. Am J Hematol 10:79, 1981
8. Triplett DA, Brandt JT, McGann Batard MA, Schaeffer Dixon JL, Fair DS: Hereditary factor VII deficiency: Heterogeneity defined by combined functional and immunochemical analysis. Blood 66:1284, 1985
9. Cooper D, Millar D, Wacey A, Banner D, Tuddenham E: Inherited factor VII deficiency: Molecular, genetic and pathophysiology. Thromb Haemost 78:151, 1997
10. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jonew HW, Rary JM: Analysis of human Y chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245, 1977
11. Arbini AA, Bodkin D, Lopaciuk S, Bauer KA: Molecular analysis of Polish patients with factor VII deficiency. Blood 84:2214, 1994
12. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn CT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487, 1988
13. Broze GJ, Jr: Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII. J Clin Invest 76:937, 1985
14. 359 Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. Blood 87:5085, 1996
15. Kaufman RJ, Davies MV, Wasley LC, Michnick D: Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res 19:4485, 1991
16. Chasin LA, Urlaub G: Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc Natl Acad Sci USA 77:4216, 1980
17. Jensen T, Loo M, Pind S, Williams D, Goldberg A, Riordan J: Multiple proteolytic systems including the proteasome, contribute to CFTR processing. Cell 83:129, 1995
18. Lukacs G, Mohamed A, Kartner N, Chang X, Riordan J, Grinstein S: Conformational maturation of CFTR but not its mutant counterpart (?F508) occurs in the endoplasmic reticulum and require ATP. EMBO J 13:6076, 1994
19. Pipe S, Kaufman R: Factor VIII C2 domain missense mutations exhibit defective trafficking of biologically functional proteins. J Biol Chem 271:25671, 1996
20. Field M, Moran P, Li W, Keller G, Caras I: Retention and degradation of proteins containing an uncleaved glycosylphosphatidylinositol signal. J Biol Chem 269:10830, 1994
21. Qu D, Teckman J, Omura S, Perlmutter D: Degradation of a mutant secretory protein, α1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem 271:22791, 1996
22. Peyvandi F, Mannucci P, Asti D, Abdoullah M, Di Rocco N, Sharifian R: Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Hemophilia 3:242, 1997
23. 353 Gln polymorphism reduces the level of coagulation factor VII: In vivo and in vitro studies. Arterioscler Thromb Vase Biol 17:2825, 1997
24. 244 Val mutation. Br J Haematol (in press)
25. Tarentino A, Maley F: Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus. J Biol Chem 249:811, 1974
26. Tarentino A, Gomez C, Plummer TJ: Deglycosylation of aspargine-linked glycans by peptide: N-glycosidase F. Biochemistry 24:4665, 1985
27. Bernards F, Patracchini P, Gemmati D, Ferrati M, Arcieri P, Papacchini M. Redaelli R, Baudo F, Mariani G, Marchetti G: Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region. Human Genet 92:446, 1993
28. Kuppuswamy M, Sabharwal A, Birktoft J, Bajaj S: Molecular characterization of human factor VII Kansas (GK704): Substitution of Gln 100 by Arg in one allele and of Arg304 by Gln possibly in the other allele. Thromb Haemost 69:1292, 1993
29. Takamiya O, Kemball-Cook G, Martin DMA, Cooper DN, von Felten A, Meili E, Hann I, Prangnell DR, Lumley H, Tuddenham EGD, McVey JH: Detection of missense mutations by single-strand conformational polymorphism (SSCP) analysis in five dysfunctional variants of coagulation factor VII. Hum Mol Gen 2:1355, 1993
30. Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G: Low plasma levels of Factor VIIc and antigen are more strongly associated with the 10 base promoter (-323) insertion than the glutamine 353 variant. Thromb Haemostas 75:567, 1996
31. Pollak ES, Hung HL, Godin G, Overton GC, High KA: Functional characterization of the human factor VII 5′ flanking region. J Biol Chem 271:1738, 1996
32. 142Glu in human lipoprotein lipase produces a missorted protein that is diverted to lysosomes. J Biol Chem 271:2139, 1996
33. Bonifacino J, Klausner R: Degradation of proteins retained in the endoplasmic reticulum. Ciechanover A, Schwartz AL (eds), vol 15. New York, NY, 1994
34. Rivett A, Mason G, Murray R, Reidlinger J: Regulation of proteasome structure and function. Mol Biol Report 24:9, 1997
35. Rock K, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg A: Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761, 1994
36. Fujiwara T, Oda K, Yokota S, Takatsuki A, Ikehara Y: Brefeldin A causes disassembly of the golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J Biol Chem 263:1854, 1988
37. Banner D, D'Arcy A, Chene C, Winkler F, Guha A, Konigsberg W. Nemerson Y, Kirchlofer D: The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 380:41, 1996
38. Bjoern S, Foster DC, Thim L, Wiberg FC, Christensen M, Komiyama Y, Pedersen AH, Kisiel W: Human plasma and recombinant factor VII: Characterization of O-glycosylations at serine residues 52 and 60 and effects of site directed mutagenesis of serine 52 to alanine. J Biol Chem 266:11051, 1991
39. 100Arg. J Biol Chem 273: 8516, 1998
40. Orning L, Stephens R, Petersen L, Hamers M: A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activation. Thromb Res 86:57, 1997